IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
1.99
-7.40%
After-hours: Aug 15, 2025, 07:58 PM EDT
IO Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 219K | n/a | 214K | 211K | 201K | 194K | 187K | 174K | 190K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | -214K | -211K | 909K | -194K | -187K | -174K | -190K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -22.58M | -26.94M | -26.5M | -21.53M | -20.2M | -28.18M | -23.48M | -21.85M | -17.92M | -20.39M | -15.87M | -18.16M | -17.01M | -21.39M | -7.04M | -8.98M | -3.81M |
Interest Income | 414K | 722K | 1.07M | 1.31M | 1.62M | 1.95M | 1.71M | 1.2M | 1.03M | 780K | 457K | 158K | 15K | n/a | n/a | n/a | n/a |
Pretax Income | -22.27M | -30.89M | -23.81M | -20.31M | -19.04M | -25.83M | -22.12M | -20.65M | -16.64M | -19.09M | -15.57M | -18.39M | -17.14M | -21.24M | -4.46M | -38.36M | -3.75M |
Net Income | -22.42M | -31.33M | -24.02M | -20.69M | -19.46M | -26.18M | -21.68M | -21.18M | -17.04M | -20.07M | -15.69M | -18.5M | -17.2M | -21.31M | -4.46M | -38.36M | -3.75M |
Selling & General & Admin | 6.21M | 5.8M | 6.33M | 5.68M | 5.89M | 6.21M | 5.83M | 5.35M | 6.02M | 5.96M | 5.84M | 5.93M | 6.7M | 4.96M | 2.91M | 2.25M | 965K |
Research & Development | 16.38M | 21.15M | 20.18M | 15.85M | 14.31M | 21.77M | 17.66M | 16.5M | 11.9M | 14.43M | 10.02M | 12.23M | 10.31M | 16.44M | 4.13M | 6.74M | 2.85M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.58M | 26.94M | 26.5M | 21.53M | 20.2M | 27.98M | 23.48M | 21.85M | 17.92M | 20.39M | 15.87M | 18.16M | 17.01M | 21.39M | 7.04M | 8.98M | 3.81M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 78K | 102K | 123K | 151K | 67K | 71K | 72K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -201K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 26.94M | 26.5M | 21.53M | 20.2M | 28.18M | 23.48M | 21.85M | 17.92M | 20.39M | 15.87M | 18.16M | 17.01M | 21.39M | 7.04M | 8.98M | 3.81M |
Income Tax Expense | 146K | 445K | 209K | 374K | 415K | 353K | -439K | 532K | 406K | 987K | 115K | 104K | 66K | 68K | n/a | 71K | n/a |
Shares Outstanding (Basic) | 65.88M | 65.88M | 65.88M | 65.88M | 65.88M | 65.88M | 50.17M | 28.82M | 28.82M | 28.82M | 28.82M | 28.82M | 28.82M | 25.73M | 25.73M | 11.55M | 11.55M |
Shares Outstanding (Diluted) | 65.88M | 65.88M | 65.88M | 65.88M | 65.88M | 65.88M | 50.17M | 28.82M | 28.82M | 28.82M | 28.82M | 28.82M | 28.82M | 25.73M | 25.73M | 11.55M | 11.55M |
EPS (Basic) | -0.34 | -0.48 | -0.36 | -0.31 | -0.3 | -0.4 | -0.43 | -0.73 | -0.59 | -0.7 | -0.54 | -0.64 | -0.6 | -0.83 | -0.17 | -3.32 | -0.32 |
EPS (Diluted) | -0.34 | -0.48 | -0.36 | -0.31 | -0.3 | -0.4 | -0.43 | -0.73 | -0.59 | -0.7 | -0.54 | -0.64 | -0.6 | -0.83 | -0.17 | -3.32 | -0.32 |
EBITDA | -22.58M | -26.72M | -26.3M | -21.32M | -19.99M | -25.63M | -21.92M | -21.66M | -17.75M | -18.89M | -15.38M | -18.29M | -16.8M | -21.09M | -4.39M | -38.29M | n/a |
EBIT | n/a | -26.94M | -26.5M | -21.53M | -20.2M | -25.83M | -22.12M | -21.85M | -17.92M | -19.08M | -15.49M | -18.29M | -17.02M | -21.09M | -4.39M | -38.29M | -3.68M |
Depreciation & Amortization | n/a | 219K | 205K | 214K | 211K | 201K | 194K | 187K | 174K | 190K | 119K | 11K | 220K | 500.00 | -1K | 1K | 3.81M |